tiprankstipranks
Trending News
More News >
CME Group (CME)
NASDAQ:CME
US Market
Advertisement

CME Group (CME) Stock Forecast & Price Target

Compare
1,871 Followers
See the Price Targets and Ratings of:

CME Analyst Ratings

Moderate Buy
14Ratings
Moderate Buy
6 Buy
6 Hold
2 Sell
Based on 14 analysts giving stock ratings to
CME
Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CME Stock 12 Month Forecast

Average Price Target

$288.23
▲(2.13% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for CME Group in the last 3 months. The average price target is $288.23 with a high forecast of $323.00 and a low forecast of $212.00. The average price target represents a 2.13% change from the last price of $282.21.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"186":"$186","255":"$255","324":"$324","220.5":"$220.5","289.5":"$289.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":323,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$323.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":288.23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$288.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":212,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$212.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[186,220.5,255,289.5,324],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,280.76,284.0092307692308,287.2584615384615,290.5076923076923,293.75692307692304,297.00615384615384,300.2553846153846,303.50461538461536,306.75384615384615,310.00307692307695,313.2523076923077,316.5015384615385,319.7507692307692,{"y":323,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,280.76,281.3346153846154,281.90923076923076,282.4838461538462,283.05846153846153,283.63307692307694,284.2076923076923,284.7823076923077,285.35692307692307,285.9315384615385,286.50615384615384,287.08076923076925,287.6553846153846,{"y":288.23,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,280.76,275.47076923076924,270.1815384615385,264.89230769230767,259.6030769230769,254.31384615384616,249.02461538461537,243.73538461538462,238.44615384615383,233.15692307692308,227.8676923076923,222.57846153846154,217.28923076923076,{"y":212,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":187.84,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":206.43,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.69,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":215.09,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":226.63,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":230.03,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":234.28,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.37,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":261.04,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.85,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":289.38,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.42,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":280.76,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$323.00Average Price Target$288.23Lowest Price Target$212.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CME
TipRanks AITipRanks
Not Ranked
TipRanks
$323
Buy
14.45%
Upside
Reiterated
08/11/25
CME Group's strong financial performance and record-breaking earnings call achievements are the primary drivers of its high score. The stock's technical indicators and valuation provide additional support, though the high P/E ratio suggests a premium valuation. Despite macroeconomic uncertainties, the company's strategic focus on growth and expansion positions it well for continued success.
Piper Sandler Analyst forecast on CME
Patrick MoleyPiper Sandler
Piper Sandler
$296
Buy
4.89%
Upside
Reiterated
08/04/25
CME Group (CME) Gets a Buy from Piper Sandler
TR | OpenAI - 4o Analyst forecast on CME
Clio ChartessaTR | OpenAI - 4o
TR | OpenAI - 4o
$317$321
Buy
13.75%
Upside
Reiterated
07/26/25
Barclays
$299$298
Hold
5.60%
Upside
Reiterated
07/24/25
CME Group (CME) Receives a Rating Update from a Top Analyst
UBS
$305
Hold
8.08%
Upside
Downgraded
07/24/25
UBS downgrades CME Group (CME) to NeutralWe are downgrading CME to Neutral from Buy following strong outperformance (+19% YTD).
Oppenheimer Analyst forecast on CME
Owen LauOppenheimer
Oppenheimer
$300$303
Buy
7.37%
Upside
Reiterated
07/24/25
Oppenheimer Sticks to Their Buy Rating for CME Group (CME)Raised our PT to $303 from $300.
KBW
$273$283
Hold
0.28%
Upside
Reiterated
07/24/25
KBW Reaffirms Their Hold Rating on CME Group (CME)
RBC Capital Analyst forecast on CME
Ashish SabadraRBC Capital
RBC Capital
$269$282
Hold
-0.07%
Downside
Reiterated
07/24/25
CME Group price target raised to $282 from $269 at RBC CapitalCME Group price target raised to $282 from $269 at RBC Capital
Morgan Stanley Analyst forecast on CME
Michael CyprysMorgan Stanley
Morgan Stanley
$304$303
Buy
7.37%
Upside
Reiterated
07/24/25
Positive Outlook for CME Group Driven by Risk Management Demand and Strong Financial Position
Bank of America Securities Analyst forecast on CME
Craig SiegenthalerBank of America Securities
Bank of America Securities
$213$212
Sell
-24.88%
Downside
Reiterated
07/23/25
Bank of America Securities Sticks to Its Sell Rating for CME Group (CME)
Raymond James
$306$309
Buy
9.49%
Upside
Reiterated
07/23/25
CME Group (CME) Gets a Buy from Raymond JamesRaymond James analyst Patrick O\\\Shaughnessy raised the price target on CME Group (NASDAQ: CME) to $309.00 (from $306.00) while maintaining a Outperform rating.
J.P. Morgan Analyst forecast on CME
Ken WorthingtonJ.P. Morgan
J.P. Morgan
$245
Sell
-13.19%
Downside
Reiterated
07/21/25
CME Group (CME) Gets a Sell from J.P. Morgan
Jefferies Analyst forecast on CME
Daniel FannonJefferies
Jefferies
$288$313
Buy
10.91%
Upside
Reiterated
07/14/25
CME Group (CME) PT Raised to $313 at JefferiesJefferies analyst Daniel Fannon raised the price target on CME Group (NASDAQ: CME) to $313.00 (from $288.00) while maintaining a Buy rating.
Citi
$275
Hold
-2.55%
Downside
Reiterated
07/03/25
CME Group: Hold Rating Amid Record Volume and Cautious Outlook
Erste Group Analyst forecast on CME
Hans EngelErste Group
Erste Group
Hold
Downgraded
05/23/25
CME Group downgraded to Hold from Buy at Erste GroupCME Group downgraded to Hold from Buy at Erste Group
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CME
TipRanks AITipRanks
Not Ranked
TipRanks
$323
Buy
14.45%
Upside
Reiterated
08/11/25
CME Group's strong financial performance and record-breaking earnings call achievements are the primary drivers of its high score. The stock's technical indicators and valuation provide additional support, though the high P/E ratio suggests a premium valuation. Despite macroeconomic uncertainties, the company's strategic focus on growth and expansion positions it well for continued success.
Piper Sandler Analyst forecast on CME
Patrick MoleyPiper Sandler
Piper Sandler
$296
Buy
4.89%
Upside
Reiterated
08/04/25
CME Group (CME) Gets a Buy from Piper Sandler
TR | OpenAI - 4o Analyst forecast on CME
Clio ChartessaTR | OpenAI - 4o
TR | OpenAI - 4o
$317$321
Buy
13.75%
Upside
Reiterated
07/26/25
Barclays
$299$298
Hold
5.60%
Upside
Reiterated
07/24/25
CME Group (CME) Receives a Rating Update from a Top Analyst
UBS
$305
Hold
8.08%
Upside
Downgraded
07/24/25
UBS downgrades CME Group (CME) to NeutralWe are downgrading CME to Neutral from Buy following strong outperformance (+19% YTD).
Oppenheimer Analyst forecast on CME
Owen LauOppenheimer
Oppenheimer
$300$303
Buy
7.37%
Upside
Reiterated
07/24/25
Oppenheimer Sticks to Their Buy Rating for CME Group (CME)Raised our PT to $303 from $300.
KBW
$273$283
Hold
0.28%
Upside
Reiterated
07/24/25
KBW Reaffirms Their Hold Rating on CME Group (CME)
RBC Capital Analyst forecast on CME
Ashish SabadraRBC Capital
RBC Capital
$269$282
Hold
-0.07%
Downside
Reiterated
07/24/25
CME Group price target raised to $282 from $269 at RBC CapitalCME Group price target raised to $282 from $269 at RBC Capital
Morgan Stanley Analyst forecast on CME
Michael CyprysMorgan Stanley
Morgan Stanley
$304$303
Buy
7.37%
Upside
Reiterated
07/24/25
Positive Outlook for CME Group Driven by Risk Management Demand and Strong Financial Position
Bank of America Securities Analyst forecast on CME
Craig SiegenthalerBank of America Securities
Bank of America Securities
$213$212
Sell
-24.88%
Downside
Reiterated
07/23/25
Bank of America Securities Sticks to Its Sell Rating for CME Group (CME)
Raymond James
$306$309
Buy
9.49%
Upside
Reiterated
07/23/25
CME Group (CME) Gets a Buy from Raymond JamesRaymond James analyst Patrick O\\\Shaughnessy raised the price target on CME Group (NASDAQ: CME) to $309.00 (from $306.00) while maintaining a Outperform rating.
J.P. Morgan Analyst forecast on CME
Ken WorthingtonJ.P. Morgan
J.P. Morgan
$245
Sell
-13.19%
Downside
Reiterated
07/21/25
CME Group (CME) Gets a Sell from J.P. Morgan
Jefferies Analyst forecast on CME
Daniel FannonJefferies
Jefferies
$288$313
Buy
10.91%
Upside
Reiterated
07/14/25
CME Group (CME) PT Raised to $313 at JefferiesJefferies analyst Daniel Fannon raised the price target on CME Group (NASDAQ: CME) to $313.00 (from $288.00) while maintaining a Buy rating.
Citi
$275
Hold
-2.55%
Downside
Reiterated
07/03/25
CME Group: Hold Rating Amid Record Volume and Cautious Outlook
Erste Group Analyst forecast on CME
Hans EngelErste Group
Erste Group
Hold
Downgraded
05/23/25
CME Group downgraded to Hold from Buy at Erste GroupCME Group downgraded to Hold from Buy at Erste Group
Stocks with the Highest Top Analyst Consensus in the Financial Sector
Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CME Group

1 Month
xxx
Success Rate
13/20 ratings generated profit
65%
Average Return
+0.32%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 65.00% of your transactions generating a profit, with an average return of +0.32% per trade.
3 Months
xxx
Success Rate
26/34 ratings generated profit
76%
Average Return
+4.06%
reiterated a xxx
rating 28 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 76.47% of your transactions generating a profit, with an average return of +4.06% per trade.
1 Year
Daniel FannonJefferies
Success Rate
28/34 ratings generated profit
82%
Average Return
+15.71%
reiterated a buy rating 28 days ago
Copying Daniel Fannon's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +15.71% per trade.
2 Years
xxx
Success Rate
31/34 ratings generated profit
91%
Average Return
+34.99%
reiterated a xxx
rating 28 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 91.18% of your transactions generating a profit, with an average return of +34.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CME Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
19
19
19
16
13
Hold
14
12
14
15
13
Sell
4
2
2
2
2
Strong Sell
0
0
0
0
0
total
37
33
35
33
28
In the current month, CME has received 13 Buy Ratings, 13 Hold Ratings, and 2 Sell Ratings. CME average Analyst price target in the past 3 months is 288.23.
Each month's total comprises the sum of three months' worth of ratings.

CME Financial Forecast

CME Earnings Forecast

Next quarter’s earnings estimate for CME is $2.71 with a range of $2.52 to $2.94. The previous quarter’s EPS was $2.96. CME beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 65.14% of the time in the same period. In the last calendar year CME has Outperformed its overall industry.
Next quarter’s earnings estimate for CME is $2.71 with a range of $2.52 to $2.94. The previous quarter’s EPS was $2.96. CME beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 65.14% of the time in the same period. In the last calendar year CME has Outperformed its overall industry.

CME Sales Forecast

Next quarter’s sales forecast for CME is $1.57B with a range of $1.48B to $1.68B. The previous quarter’s sales results were $1.69B. CME beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 79.74% of the time in the same period. In the last calendar year CME has Outperformed its overall industry.
Next quarter’s sales forecast for CME is $1.57B with a range of $1.48B to $1.68B. The previous quarter’s sales results were $1.69B. CME beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 79.74% of the time in the same period. In the last calendar year CME has Outperformed its overall industry.

CME Stock Forecast FAQ

What is CME’s average 12-month price target, according to analysts?
Based on analyst ratings, CME Group’s 12-month average price target is 288.23.
    What is CME’s upside potential, based on the analysts’ average price target?
    CME Group has 2.13% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CME a Buy, Sell or Hold?
          CME Group has a consensus rating of Moderate Buy which is based on 6 buy ratings, 6 hold ratings and 2 sell ratings.
            What is CME Group’s price target?
            The average price target for CME Group is 288.23. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $323.00 ,the lowest forecast is $212.00. The average price target represents 2.13% Increase from the current price of $282.21.
              What do analysts say about CME Group?
              CME Group’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of CME?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis